The Cooper Companies, Inc. (COO)
NASDAQ: COO · Real-Time Price · USD
73.26
-0.18 (-0.25%)
At close: Aug 15, 2025, 4:00 PM
74.02
+0.76 (1.04%)
After-hours: Aug 15, 2025, 6:39 PM EDT

Company Description

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers.

The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia; and spherical lense, including lenses that correct near and farsightedness in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

The CooperSurgical segment focuses on family and women’s health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide.

It offers surgical and office products, including paragard contraceptive intrauterine devices; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing.

The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers.

The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

The Cooper Companies, Inc.
The Cooper Companies logo
CountryUnited States
Founded1980
IndustryMedical Instruments & Supplies
SectorHealthcare
Employees16,000
CEOAlbert White

Contact Details

Address:
6101 Bollinger Canyon Road, Suite 500
San Ramon, California 94583
United States
Phone925 460 3600
Websitecoopercos.com

Stock Details

Ticker SymbolCOO
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearNovember - October
Reporting CurrencyUSD
CIK Code0000711404
CUSIP Number216648402
ISIN NumberUS2166485019
Employer ID94-2657368
SIC Code3851

Key Executives

NamePosition
Albert G. White IIIPresident, Chief Executive Officer and Non-Independent Director
Brian G. AndrewsExecutive Vice President, Chief Financial Officer and Treasurer
Daniel G. McBride Esq.Executive Vice President and Chief Operating Officer
Holly R. SheffieldPresident of CooperSurgical, Inc.
Gerard H. Warner IIIPresident of CooperVision, Inc.
Agostino Ricupati CPASenior Vice President and Chief Accounting Officer
Kim DuncanVice President of Investor Relations and Risk Management
Nicholas S. Khadder J.D.Vice President, General Counsel and Corporate Secretary

Latest SEC Filings

DateTypeTitle
May 30, 2025SDForm - SD
May 30, 202510-QQuarterly Report
May 29, 20258-KCurrent Report
Apr 30, 20258-KCurrent Report
Apr 17, 2025SCHEDULE 13G/AFiling
Apr 2, 20258-KCurrent Report
Mar 7, 202510-QQuarterly Report
Mar 6, 20258-KCurrent Report
Feb 19, 2025DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material
Feb 19, 2025DEF 14AOther definitive proxy statements